Facebook
Twitter
LinkedIn
Forward
Emerging Strategies in the Upfront Treatment of Hodgkin Lymphoma (Live Webinars)
Join Robert Chen, MD from City of Hope Comprehensive Cancer Center for this NCCN webinar presentation, Emerging Strategies in the Upfront Treatment of Hodgkin Lymphoma.
Please note that the same educational content will be presented on
both days listed under the Schedule and Register tabs.
You can only register for one of the live webinars on this topic.
Target Audience
This initiative is designed to meet the needs of oncologists, hematologists, nurses, pharmacists, physician assistants, and other health care professionals treating Hodgkin lymphoma (HL) patients.
Learning Objectives
Following this activity, participants should be able to:
- Describe the need for improved treatment options for newly diagnosed Hodgkin lymphoma (HL) patients.
- Discuss the upfront use of antibody-drug conjugates combined with standard chemotherapy.
- Comment on the upfront use of PD-1 immune checkpoint inhibitors.
Please note that the same educational content will be presented on both days listed below.
You can only register for one of the live webinars on this topic.
Emerging Strategies in the Upfront Treatment of Hodgkin Lymphoma
Thursday, February 22, 2018 • 3:30 - 4:45 PM [EST]
Robert Chen, MD, City of Hope Comprehensive Cancer Center
Emerging Strategies in the Upfront Treatment of Hodgkin Lymphoma
Monday, February 26, 2018 • 12:30 - 1:45 PM [EST]
Robert Chen, MD, City of Hope Comprehensive Cancer Center
ALL WEBINAR TIMES ARE POSTED AS EASTERN STANDARD TIME (EST) (UTC/GMT -5:00).
Access to participate in selected sessions is through the NCCN WebEx Site on the day of each scheduled program.
Robert Chen, MD
City of Hope Comprehensive Cancer Center
Disclosure of Relevant Financial Relationships
All faculty and activity planners participating in NCCN continuing education activities are expected to disclose any relevant financial relationships with a commercial interest as defined by the ACCME’s, ANCC’s, and ACPE’s Standards for Commercial Support. All faculty presentations have been reviewed for adherence to the ACCME’s Criterion 7: The provider develops activities/educational interventions independent of commercial interests (SCS 1, 2, and 6) by experts on the topics. Full disclosure of faculty relationships will be made prior to the activity.
Physicians
National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
NCCN designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.25 hours of Category I credit for completing this activity.
Nurses
National Comprehensive Cancer Network (NCCN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
NCCN designates this educational activity for a maximum of 1.25 contact hours.
Pharmacists
| National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. |
NCCN designates this knowledge-based continuing education activity for 1.25 contact hours (0.125 CEUs) of continuing education credit. UAN = 0836-0000-18-016-L01-P
Price
Please note that the same educational content will be presented on both days listed above.
View the Schedule tab for webinar times. You can only register for one of the live webinars on this topic.
Required Hardware/software
To complete this activity, users will need:
- A device with an Internet connection and sound playback capability
- One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari
- Internet Explorer is no longer supported
- Adobe Reader or other PDF reader software for certificate viewing/printing